121 related articles for article (PubMed ID: 34331023)
1. Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma.
Chen D; Bao X; Zhang R; Ding Y; Zhang M; Li B; Zhang H; Li X; Tong Z; Liu L; Zhou X; Wang S; Cheng X; Zheng Y; Ruan J; Fang W; Zhao P
Br J Cancer; 2021 Sep; 125(7):994-1002. PubMed ID: 34331023
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of chemotherapy and operation in patients with colorectal neuroendocrine carcinoma.
Wu Z; Yu D; Zhao S; Gao P; Song Y; Sun Y; Chen X; Wang Z
J Surg Res; 2018 May; 225():54-67. PubMed ID: 29605035
[TBL] [Abstract][Full Text] [Related]
3. Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.
Wang Q; Yin R; Tang W; Li C; Zheng H; Zhang X; Jin X; Ying M; Fu J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Nov; 51(5):594-602. PubMed ID: 36581574
[TBL] [Abstract][Full Text] [Related]
4. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
Chew V; Chen J; Lee D; Loh E; Lee J; Lim KH; Weber A; Slankamenac K; Poon RT; Yang H; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP
Gut; 2012 Mar; 61(3):427-38. PubMed ID: 21930732
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
6. Active secretion of CXCL10 and CCL5 from colorectal cancer microenvironments associates with GranzymeB+ CD8+ T-cell infiltration.
Zumwalt TJ; Arnold M; Goel A; Boland CR
Oncotarget; 2015 Feb; 6(5):2981-91. PubMed ID: 25671296
[TBL] [Abstract][Full Text] [Related]
7. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract][Full Text] [Related]
8. Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
Young K; Lawlor RT; Ragulan C; Patil Y; Mafficini A; Bersani S; Antonello D; Mansfield D; Cingarlini S; Landoni L; Pea A; Luchini C; Piredda L; Kannan N; Nyamundanda G; Morganstein D; Chau I; Wiedenmann B; Milella M; Melcher A; Cunningham D; Starling N; Scarpa A; Sadanandam A
Gut; 2021 Oct; 70(10):1904-1913. PubMed ID: 32883872
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand-1 expression in gastroenteropancreatic neuroendocrine tumors.
Oktay E; Yalcin GD; Ekmekci S; Kahraman DS; Yalcin A; Degirmenci M; Dirican A; Altin Z; Ozdemir O; Surmeli Z; Diniz G; Ayhan S; Bulut G; Erdogan A; Uslu R
J BUON; 2019; 24(2):779-790. PubMed ID: 31128036
[TBL] [Abstract][Full Text] [Related]
10. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas.
Akintola-Ogunremi O; Pfeifer JD; Tan BR; Yan Y; Zhu X; Hart J; Goldblum JR; Burgart L; Lauwers GY; Montgomery E; Lewin D; Washington K; Bronner M; Xiao SY; Greenson JK; Lamps L; Lazenby A; Wang HL
Am J Surg Pathol; 2003 Dec; 27(12):1551-8. PubMed ID: 14657715
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
[TBL] [Abstract][Full Text] [Related]
12. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
[TBL] [Abstract][Full Text] [Related]
13. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
14. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of association between center colorectal neuroendocrine neoplasm volume and survival among patients with colorectal neuroendocrine carcinoma.
Suraju MO; Freischlag K; McKeen A; Nayyar A; Thompson D; Gordon DM; Mishra A; Sherman SK; Goffredo P; Hassan I
J Surg Oncol; 2024 Apr; ():. PubMed ID: 38685721
[TBL] [Abstract][Full Text] [Related]
16. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
Front Immunol; 2021; 12():657951. PubMed ID: 34531849
[TBL] [Abstract][Full Text] [Related]
18. CCL5-deficiency enhances intratumoral infiltration of CD8
Zhang S; Zhong M; Wang C; Xu Y; Gao WQ; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):766. PubMed ID: 29991744
[TBL] [Abstract][Full Text] [Related]
19. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors.
George J; Walter V; Peifer M; Alexandrov LB; Seidel D; Leenders F; Maas L; Müller C; Dahmen I; Delhomme TM; Ardin M; Leblay N; Byrnes G; Sun R; De Reynies A; McLeer-Florin A; Bosco G; Malchers F; Menon R; Altmüller J; Becker C; Nürnberg P; Achter V; Lang U; Schneider PM; Bogus M; Soloway MG; Wilkerson MD; Cun Y; McKay JD; Moro-Sibilot D; Brambilla CG; Lantuejoul S; Lemaitre N; Soltermann A; Weder W; Tischler V; Brustugun OT; Lund-Iversen M; Helland Å; Solberg S; Ansén S; Wright G; Solomon B; Roz L; Pastorino U; Petersen I; Clement JH; Sänger J; Wolf J; Vingron M; Zander T; Perner S; Travis WD; Haas SA; Olivier M; Foll M; Büttner R; Hayes DN; Brambilla E; Fernandez-Cuesta L; Thomas RK
Nat Commun; 2018 Mar; 9(1):1048. PubMed ID: 29535388
[TBL] [Abstract][Full Text] [Related]
20. Genetic Characteristics of Colorectal Neuroendocrine Carcinoma: More Similar to Colorectal Adenocarcinoma.
Chen L; Liu M; Zhang Y; Guo Y; Chen MH; Chen J
Clin Colorectal Cancer; 2021 Jun; 20(2):177-185.e13. PubMed ID: 33041225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]